Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesA small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC
British Journal of Cancer, 11/13/09
Dean EJ et al. – These preclinical data suggest that XIAP inhibition in combination with vinorelbine holds potential as a therapeutic strategy in NSCLC.
Related Articles
Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: Final results of the FinHer Trial
Journal of Clinical Oncology, 11/05/09
Relevance Score: 91%
Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma
Oncology (Karger), 11/17/09
Relevance Score: 88%
Phase II trial of single-agent oral vinorelbine in elderly (70 years) patients with advanced non-small-cell lung cancer and poor performance status
Annals of Oncology, 11/19/09
Relevance Score: 85%
Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
Clinical Cancer Research, 10/12/09
Relevance Score: 85%
Inflammatory myofibroblastic tumor of the conjunctiva: Response to chemotherapy with low-dose methotrexate and vinorelbine
Pediatric Blood & Cancer, 11/12/09
Relevance Score: 84%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer
Oncogene, 03/22/10
Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression
Oncogene, 03/22/10
ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1
Oncogene, 03/22/10
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Genetic variants and risk of lung cancer in never smokers: A genome-wide association study
The Lancet Oncology - Online First, 03/22/10
Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study
BMC Cancer, 03/22/10
Cetuximab combined with chemotherapy in non-small cell lung cancer
Community Oncology , 03/22/10
Sponsor
Article Search
Sponsor
Sponsor